180 related articles for article (PubMed ID: 38487536)
1. Intratumoral CXCR4
Lu Z; Wang X; Feng J; Chai W; Wang W; Wang Q; Yang S; Yang W; Su Y; Mou W; Peng Y; Wang H; Gui J
Front Immunol; 2024; 15():1363454. PubMed ID: 38487536
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
[TBL] [Abstract][Full Text] [Related]
3. Annexin A1 Is a Physiological Modulator of Neutrophil Maturation and Recirculation Acting on the CXCR4/CXCL12 Pathway.
Machado ID; Spatti M; Hastreiter A; Santin JR; Fock RA; Gil CD; Oliani SM; Perretti M; Farsky SH
J Cell Physiol; 2016 Nov; 231(11):2418-27. PubMed ID: 26892496
[TBL] [Abstract][Full Text] [Related]
4. The stromal cell-derived factor 1/C-X-C chemokine receptor type 4 axis is important in neutrophil migration caused by cardiopulmonary bypass in children.
Tu R; Peng Y; Wang Y; Tang X; Wang S
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):431-437. PubMed ID: 29106576
[TBL] [Abstract][Full Text] [Related]
5. PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.
Marayati R; Julson J; Bownes LV; Quinn CH; Stafman LL; Beierle AM; Markert HR; Hutchins SC; Stewart JE; Crossman DK; Hjelmeland AB; Mroczek-Musulman E; Beierle EA
Clin Exp Metastasis; 2022 Dec; 39(6):899-912. PubMed ID: 36315303
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma.
Wang Y; Xiang X; Chen H; Zhou L; Chen S; Zhang G; Liu X; Ren X; Liu J; Kuang M; Jiang J; She J; Zhang Z; Xue R; Jiang H; Wang J; Peng S
Cell Rep Med; 2023 May; 4(5):101044. PubMed ID: 37196629
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma.
Huang S; Chen J; Tian R; Wang J; Xie C; Gao H; Shan Y; Hong J; Zhang Z; Xu M; Gu S
Pediatr Blood Cancer; 2018 Jul; 65(7):e27032. PubMed ID: 29528187
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CD44 expression in children with hepatoblastoma.
Cai HY; Yu B; Feng ZC; Qi X; Wei XJ
Genet Mol Res; 2015 Oct; 14(4):13203-7. PubMed ID: 26535633
[TBL] [Abstract][Full Text] [Related]
11. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
Liu Y; Song J; Liu Y; Zhou Z; Wang X
J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
[TBL] [Abstract][Full Text] [Related]
12. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.
Zeng Y; Li B; Liang Y; Reeves PM; Qu X; Ran C; Liu Q; Callahan MV; Sluder AE; Gelfand JA; Chen H; Poznansky MC
FASEB J; 2019 May; 33(5):6596-6608. PubMed ID: 30802149
[TBL] [Abstract][Full Text] [Related]
13. CXCR4
Garcia F; Mendonça R; Miguel LI; Dominical VM; Saad STO; Costa FF; Conran N
Sci Rep; 2020 Aug; 10(1):14262. PubMed ID: 32868775
[TBL] [Abstract][Full Text] [Related]
14. The CXCL12/CXCR4 Signaling Axis Retains Neutrophils at Inflammatory Sites in Zebrafish.
Isles HM; Herman KD; Robertson AL; Loynes CA; Prince LR; Elks PM; Renshaw SA
Front Immunol; 2019; 10():1784. PubMed ID: 31417560
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
Fernandis AZ; Cherla RP; Ganju RK
J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
[TBL] [Abstract][Full Text] [Related]
16. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells.
Tulotta C; Stefanescu C; Chen Q; Torraca V; Meijer AH; Snaar-Jagalska BE
Sci Rep; 2019 Feb; 9(1):2399. PubMed ID: 30787324
[TBL] [Abstract][Full Text] [Related]
18. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
Daniel SK; Seo YD; Pillarisetty VG
Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
20. The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury.
Yamada M; Kubo H; Kobayashi S; Ishizawa K; He M; Suzuki T; Fujino N; Kunishima H; Hatta M; Nishimaki K; Aoyagi T; Tokuda K; Kitagawa M; Yano H; Tamamura H; Fujii N; Kaku M
Cell Mol Immunol; 2011 Jul; 8(4):305-14. PubMed ID: 21460863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
